. (1983). . The chronic toxicity and oncogenic potential of ingested vinylidene chloride (VDC) was evaluated in a 2-year study on Sprague-Dawley rats and the subchronic toxicity was evaluated in beagle dogs in a 97-day study. The vinylidene chloride was incorporated in the drinking water of the rats at nominal concentrations of 50,100 or 200 ppm. The time weighted average mg/kg body weight/ day dosages of vinylidene chloride administered to the male and female rats over the 2-year period at the various mean analyzed concentrations were 7, I 0 or 20 for the males and 9, 14 or 30 for the females. Dogs were administered vinylidene chloride in peanut oil incorporated in a gelatin capsule at concentrations which provided 6.25, 12.5 or 25 mg vinylidene chloride/kg body weight/day. There were no significant differences between the groups of rats or dogs ingesting vinylidene chloride and their corresponding control groups in the following parameters: appearance and demeanor, mortality, body weight, food consumption, hematology, urinalysis, clinical chemistry determinations, organ weights and organ to body weight ratios. There were no significant differences in water consumption ofthe groups of rats ingesting vinylidene chloride and the controls. The sole tr~atment-related observation in the rats, evident only upon microscopic examination, was in the liver. The observation was characterized by a minimal amount of hepatocellular sweUing with midzonal fatty change which occurred in the females at all dose levels and in the males only at the 200 ppm level. No exposure-related neoplastic changes occurred in the rats in any of the test groups. No exposure-related gross or histopathological changes were present in the tissues taken from the dogs at the termination of the 97-day study.
INTRODUCTION
Vinylidene chloride ( 1,1 -dichloroethylene, CH 2 =CCI2. VDC) ~s used in the manufacture of various barrier resins and films lor food packaging. Reports on the acute toxicity of vinylidene chloride in laboratory animals have indicated moderate toxic-
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Y _•n~alation and by gavage (Carpenter eta! .. 1949; Rylova, Previous studies by Viola and Caputo ( 1977) and Maltoni et a/. (1977) have shown that 75 to 100 ppm VDC vapor is noncarcinogenic in the rat. Maltoni et a/. (1977) reported that tumorigenicity of 25 ppm VDC in the kidneys of male mice was associated with significant injury to that organ and that male mice were far more susceptible to the toxic effect of VDC than were the female mice.
McKenna eta/. (1977) have shown that the metabolism of VDC by male mice to electrophilic species which bind to cellular macromolecules correlated with the reported tumorigenic response in male mice. Recent studies reported by Reitz eta!. ( 1980) suggest the primary contributing factor in the induction of the kidney tumors in the male mouse is cytotoxicity as indicated by histopathology and is associated with a sig'nificant increase in DNA synthesis.
The objectives of the studies reported herein were to investigate the toxicological properties of VDC in dogs and rats and to determine its oncogenic potential following lifetime administration to rats. The VDC was administered by capsule to the dogs and in the drinking water of rats. Incorporation in the drinking water was selected because the concentration could be held relatively constant in the water over a 24-hour period whereas it was rapidly lost when incorporated in feed.
METHODS

Material
The VDC samples used in the studies were aliquots of production material, minimum purity.99.5%, obtained from The Dow Chemical Company. Since the VDC used in the preparation of various copolymers is distilled to remove the inhibitor monomethyl ether of hydroquinone (MEHO). the samples used in the studies were distilled to bring the residual MEHQ into the range of 1 to 5 ppm. The stability of VDC in water and peanut oil was verified before the initiation of the studies.
Drinking water containing the VDC was prepared daily and analyzed at periodic intervals during the study. The means± S.D. of these analyses were 68 ± 21 ppm, 99 ± 22 ppm, and 206 ± 33 ppm for the respective nominal concentrations of 50, 100 and 200 ppm VDC.
Gelatin capsules for administration of the VDC to the dogs were filled weekly using th~ required amount of a 50% solution of VDC in peanut oil per capsule to provide the designated dosage on a mg/kg body weight basis. The dosages of 6.25, 12.5 and 25.0 were chosen to approximate 6250, 12 500 and 25 000 times, respectively, the amount of VDC ingested by a 75 kg person on a 1500 gram daily diet. assuming the food was in packages containing the compound and migration was 50 ppb in the food. 
Experimental design
Male and femal~ Sprague-Dawley rats, Spartan substrain, 1 6 to 7 weeks old, were randomly placed (2/cage) into suspended wire bottom cages for use in the 2-year chronic toxicity and oncogenicity study. Male and female purebred beagle dogs, 2 8 months of age, were housed (4/pen) for use in the 97-day subchronic study. Food and water for the rats 3 and dogs 4 were made available to the animals ad libitum.
Groups of 48 rats/sex were maintained for up to 2 years on drinking water containing nominal concentrations of 50, 100 or 200 ppm VDC. A group of 80 rats/sex used as controls were supplied drinking water without VDC. Groups of 4 dogs/sex were administered one capsule containing VDC in peanut oil to provide dosages of 6.25, 12.5 or 25 mg VDC/kg body weight/day on each day of the 97-day study. A group of 4 control dogs/sex were daily administered a capsule containing an amount of peanut oil equivalent to that given to the dogs at the 25 mg/kg body weight dose level.
The rats were observed at least twice weekly for changes in appearance or demeanor. signs of toxicity and evidence of neoplasm formation. Biweekly food consumption and daily water consumption were determined during the first 3 months; thereafter the determinations were made at periodic intervals. Body weights were taken weekly for the first 14 weeks and then monthly thereafter. Hematologic determinations and urinalysis were conducted on at least 5 rats/sex/control and test groups at 6, 12. 18 and 23 months of the study. The packed cell volume, erythrocyte count, hemoglobin concentration, total and differentia(leucocyte counts were determined.' Urinalysis included determination of specific gravity, pH, sugar, proteiv. ketones, occult blood and bilirubin 6 Clinical chemistry studies were conducted on 5 rats/sex/control and test groups at 6. 12, and 18 months and from 10 rats/sex/group or from all survivors if less than 10 animals remained at terminal necropsy The parameters monitored included blood urea nitrogen serum alkaline phosphatase activity, serum glutamic pyrivic transaminase activity and glucose concentration.
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All rats that were found moribund or dead during the cours! of the study were subjected to gross pathological examination At terminal necropsy following overnight deprivation of food the brain, heart, liver, kidneys, and testes were weighed. Thf following tissues were taken from rats dying spontaneously found moribund or surviving until terminal necropsy: esopha gus. salivary glands, stomach, large intestine, pancreas, liver kidney, urinary bladder, prostate, accessory sex glands, ep1 didymis, testes, ovaries. oviducts. uterus. mammary tissuE brain (cerebrum, cerebellum, brain stem), pituitary gland, sp1 nat cord, peripheral nerve, trachea, lungs; nasal turbinate! sternum and sternal bone marrow, spleen, mediastinal lyrr phoid tissue, lymph nodes (mesenteric), heart, aorta, skelet< muscle, adrenal glands, thyroid and parathyroid glands, ad pose tissue, skin, eye and any gross lesions suggestive of significant pathological alteration or neoplasm formation.
Microscopic examinations were generally made on con plete sets of tissues prepared by routine histological proc1 dures and stained with hematoxylin and eosin, which wer taken at the time of necropsy from all control and 200 PP' dose level animals. Selected target organs and grossly recognized neoplastic changes in the rats receiving 100 or 50 ppm VDC in the drinking water were also examined microscopically.
The dogs were observed daily for signs of toxicity. Food :onsumption/pen was recorded twice each week and the 3verage amount consumed/dog/day was calculated. Hematoogic determinations including packed cell volume, erythrocyte count, hemoglobin concentration, total and differential leukoCYte counts were conducted 5 on all dogs prior to the start ofthe study and on test days 33 and 84. Urinalysis involving specific gravity, sugar, protein, ketones, occult blood. bilirubin 6 and rrHcroscopic examination of sediment were conducted on all :;egs on test day 83, and prior to the terminal necropsy. Clinical :hemistry determinations of blood urea nitrogen, serum gluarnic pyruvic transaminase activity, alkaline phosphatase activity and serum glutamic oxaloacetic transaminase activity ••ore made. following overnight deprivation of food, prior to · ~" 1 e start of the study and subsequently thereafter at the same nne urinalyses were conducted. The non-protein free sulf-'Ydryl content of a portion of liver and kidneys was determined ;sing the method of Sedlak and Lindsay ( 1968) for each dog at ""time of necropsy. At the terminal sacrifice. following overnight deprivation of food, the weights of the brain, heart. liver. kidneys and testes were recorded. Portions of the same tissues and organs (except for the nasal turbinate) taken from the rats on the chronic toxicity and oncogenicity study were taken from the dogs. Microscopic examination was conducted on a complete set of tissues from control and 200 ppm dose level animals and on liver. kidney and lung tissue from the 100 and 50 ppm dose level animals. Ophthalmological examinations were conducted by slit lamp ophthalmoscopy of all animals prior to the start of the study and at the termination of the study. At terminal necropsy, both eyes of all dogs were examined grossly and microscopic examination was conducted on the eyes from control and top dose level dogs.
Statistical evaluation of body weight and organ weight data, food consumption (rats only), water consumption (rats only), and hematology and clinical chemistry determinations were made using an analysis of variance and Dunnett's test (Steel and Torrie. 1960) . Since the dogs were housed together regression analysis was used to detect trends in food consumption. In the rats all mortality and neoplasm incidence data were analyzed using the Fisher Exact Probability Test (Siegel, 1 956) . The level of significance in all cases was p < 0.05. ..._;
• li I RESULTS Rats were administered VDC in the dnnking water at nominal concentrations of 50, 100 or 200 ppm during the 2-year period. Based on the mean analyzed concentrations in the drinking water, the rats were determined to have ingested 7, 10 and 20 mg/kg/day, respectively, for the males and 9, 14 and 30 mg/kg/day, respectively, for the females. Throughout the 2 year study, the appearance and demeanor of the rats ingesting VDC in their drinking water were not different from that of the control animals. Except for occasional statistically significant differences in the cumulative mortality percentages, the mortality among the test animals was comparable to the controls (figures 1 and 2).
Mean body weights of the rats over the 2-year period were similar for all groups (Figure 3 ). Occasionally occurring statistically significant differences (increases and decreases) in food and water consumption data were neither dose-related nor time-related and were not considered to be related to the ingestion of VDC.
All values for the hematological determinations and urinalyses obtained on animals from control and test groups were within the normal range for this laboratory. No consistent or dose-related differences were observed in the clinical chemistry parameters or sulfhydryl levels evaluated and the various time periods in any of the test groups.
Mean organ weights, fasted body weights and organ to body weight ratios were not significantly different for any of the test groups when compared to the values for the control group. The only pathological findings considered to be related to the ingestion of VDC, evident only upon microscopic examination, were those involving the liver. The hepatic changes, when present, were usually characterized by a minimal amount of mid-zonal hepatocellular fatty change in both male and female rats. In the male rats, only those in the 200 ppm group showed a statistically significantly increased incidence of hepatocellular fatty change. This group of rats also showed an increased incidence of hepatocellular swelling. A trend towards an increased incidence of hepatic changes was observed in the male rats in the 100 ppm group. No exposure-related hepatic . changes were recognized in the 50 ppm group of male rats. Minimal hepatocellular fatty change and hepatocellular swelling were detected in female rats at all dose levels. No significant hepatocellular necrosis considered exposure-related was evident in either male or female rats at any of the dose levels.
Evaluation of the neoplasm data revealed an increased incidence of mammary gland fibroadenomas/adenofibromas in the females ingesting drinking water containing 50 ppm VDC. Since the incidence was within the normal range of the historical control data from this laboratory and was not dose-related, it was not considered to be related to the ingestion of VDC. The histopathologic diagnosis and number of neoplasms observed, including the mammary gland fibroadenomas/adenofibromas, is presented in Appendix Table 1 .
No other neoplastic types were observed which were significantly increased or decreased in either female or male rats. The total incidence of histopathologically diagnosed neoplasms, benign and malignant, is summarized in Table 1 . The total neoplasm incidence in the male and female rats in the various test groups was not different than the incidence in the control animals.
Dogs administered daily dosages of VDC of 6.25, 12.5 or 25 mg/kg/day over a 97-day period showed no exposurerelated changes in appearance and demeanor, body weights or food consumption.
The hematologic values for packed cell volume, red blood cell count, total white-blood cell count and hemoglobin concentration are presented in Table 2 . The mean white blood cell counts of the dogs receiving 6.25 and 25 mg/kg/day were significantly lower than the control values on day 84 of the study. Since the values for these groups of dogs were not different from their pre-exposure blood cell counts and were within the range of normal values for this laboratory, the differences were not considered to be related to the ingestior. of VDC. The clinical chemistry values are presented in Table 3 . Statiltically significant diHerences found in the values of serum glutamic pyrivic transaminase, serum glutamic oxaloacetic transaminase and blood urea nitrogen for dogs receiving 6.25 mg/kg/day were within the range of normal values observed in this laboratory. Except for one male dog receiving 25 rng/kg/day of VDC that had an elevated serum glutamic PYruvic transaminase activity on day 85 of the study but not on day 97, Flo alterations in the various determinations were observed at the 12.5 or 25 mg/kg/day levels. No alterations were observed in the non-protein free sulfhydryl levels in liver or kidney of dogs at any dose level.
No exposure-related changes were observed in any of the Parameters examined on urinalysis, in organ weights or organ to body weight ratios or in gross and microscopic examination of the tissues from either the male or female dogs at any dose level. The pathologic changes present were interpreted to be 'POntaneous in occurrence and were comparable in control and test dogs. A single male dog receiving 12.5 mg/kg/day of VDC had kidneys which grossly appeared increased in size; llowever, no significant histopathologic alterations were recognized in this animal. Evaluation of hematologic. clinical cl)emistry, and urinalysis values of this dog did not reveal abnormalities. In view of these negative findings and the lack of other effects at the 25 mg/kg/day level, the grossly observed large kidneys in this one dog were considered not to %related to ingestion of VDC.
DISCUSSION
At the dose levels used in this 2-year study, VDC was found ''otto be oncogenic in either the male or female Sprague-Dawley 'at. The highest concentration of VDC administered to the rats ~, the drinking water. 200 ppm, was the maximum feasible ;~ncentration based on the solubility of VDC in water. The only cytes 'Rampy et al .• 1977) . At the termination of the 2-year study, female rats at all concentrations of VDC in the drinking water and male rats at the 200 ppm concentration were observed to have no more than a minimal amount of hepatocellular fatty change and hepatocellular swelling. These minimal microscopic liver changes did not result in altered organ weight or clinical chemistry changes.
The results of previous experiments demonstrated that the fate of VDC in the rat following oral administration was dose dependent and the primary detoxification pathway was the conjugation of VDC with hepatic glutathione 'McKenna et al .. 1978; Jaeger eta/., 1974; Jaeger et al .• 1973) . The maximum tolerated dose of VDC. defined as one which results in· pathologic alterations was 200 ppm in this rat study. The 200 ppm concentration did not deplete the non-protein sulfhydryl levels in the liver o.r the kidneys or cause toxicity by virtue of saturation of the detoxification pathway 'Rampy et a/., 1977) .
At the highest dose level of VDC administered to dogs, 25 mg/kg of body weight/ day, there I ikewise was no depletion of the non-protein sulfhydryl levels in the liver or kidneys and also no exposure-related pathologic alterations in male or female dogs at any dose level.
In summary, the results of the 2-year study in rats indicate that ingestion of VDC at levels sufficient to induce alterations in the target organ, while not exceeding the capacity of the primary detoxification pathway, did not increase the overall incidence of neoplasms in this or any other organ. The results of the 97-day toxicity study in dogs demonstrated that 25 mg/kg/day, a level which did not alter the non-protein sulfhydryl levels in the liver or kidneys, did not elicit any evidence of toxicity. AExcept as noted, not significantly different from control data when analyzed using Fischer's Exact Probability Test, p < 0.05. 8 Not applicable. cData listed as number of neoplasms/number of rats with neoplasm. All gross masses were examined microscopically.
0 Significantly different from control data when analyzed using Fischer's Exact Probability test, p < 0.05. 
